Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

A TNF receptor loop peptide mimic blocks RANK ligand–induced signaling, bone resorption, and bone loss
Kazuhiro Aoki, … , William C. Horne, Roland Baron
Kazuhiro Aoki, … , William C. Horne, Roland Baron
Published June 1, 2006
Citation Information: J Clin Invest. 2006;116(6):1525-1534. https://doi.org/10.1172/JCI22513.
View: Text | PDF
Research Article Bone biology Article has an altmetric score of 9

A TNF receptor loop peptide mimic blocks RANK ligand–induced signaling, bone resorption, and bone loss

  • Text
  • PDF
Abstract

Activating receptor activator of NF-κB (RANK) and TNF receptor (TNFR) promote osteoclast differentiation. A critical ligand contact site on the TNFR is partly conserved in RANK. Surface plasmon resonance studies showed that a peptide (WP9QY) that mimics this TNFR contact site and inhibits TNF-α–induced activity bound to RANK ligand (RANKL). Changing a single residue predicted to play an important role in the interaction reduced the binding significantly. WP9QY, but not the altered control peptide, inhibited the RANKL-induced activation of RANK-dependent signaling in RAW 264.7 cells but had no effect on M-CSF–induced activation of some of the same signaling events. WP9QY but not the control peptide also prevented RANKL-induced bone resorption and osteoclastogenesis, even when TNFRs were absent or blocked. In vivo, where both RANKL and TNF-α promote osteoclastogenesis, osteoclast activity, and bone loss, WP9QY prevented the increased osteoclastogenesis and bone loss induced in mice by ovariectomy or low dietary calcium, in the latter case in both wild-type and TNFR double-knockout mice. These results suggest that a peptide that mimics a TNFR ligand contact site blocks bone resorption by interfering with recruitment and activation of osteoclasts by both RANKL and TNF.

Authors

Kazuhiro Aoki, Hiroaki Saito, Cecile Itzstein, Masaji Ishiguro, Tatsuya Shibata, Roland Blanque, Anower Hussain Mian, Mariko Takahashi, Yoshifumi Suzuki, Masako Yoshimatsu, Akira Yamaguchi, Pierre Deprez, Patrick Mollat, Ramachandran Murali, Keiichi Ohya, William C. Horne, Roland Baron

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Total
Citations: 1 2 4 4 3 2 2 7 4 2 3 2 2 3 2 1 6 1 3 54
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (54)

Title and authors Publication Year
Rhusflavone Modulates Osteoclastogenesis Through RANKL-Induced AKT Signaling in Bone Marrow-Derived Macrophages
Yun HM, Kim B, Kim E, Park KR
International Journal of Molecular Sciences 2025
Current perspectives on the multiple roles of osteoclasts: Mechanisms of osteoclast-osteoblast communication and potential clinical implications.
Daponte V, Henke K, Drissi H
eLife 2024
Novel peptide inhibitor of human tumor necrosis factor-α has antiarthritic activity
Sahu D, Gupta C, Yennamalli RM, Sharma S, Roy S, Hasan S, Gupta P, Sharma VK, Kashyap S, Kumar S, Dwivedi VP, Zhao X, Panda AK, Das HR, Liu CJ
Scientific Reports 2024
ADR3, a next generation i-body to human RANKL, inhibits osteoclast formation and bone resorption
Qiu H, Hosking C, Rothzerg E, Samantha A, Chen K, Kuek V, Jin H, Zhu S, Vrielink A, Lim K, Foley M, Xu J
The Journal of biological chemistry 2023
Mechanistic advances in osteoporosis and anti-osteoporosis therapies.
Wang H, Luo Y, Wang H, Li F, Yu F, Ye L
2023
Cell unit-inspired natural nano-based biomaterials as versatile building blocks for bone/cartilage regeneration.
Wang F, Gu Z, Yin Z, Zhang W, Bai L, Su J
Journal of nanobiotechnology 2023
RANKL/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetes
Kondegowda NG, Filipowska J, Do JS, Leon-Rivera N, Li R, Hampton R, Ogyaadu S, Levister C, Penninger JM, Reijonen H, Levy CJ, Vasavada RC
Science Advances 2023
RANKL biology
N Takegahara, H Kim, Y Choi
Bone 2022
Receptor Specificity Engineering of TNF Superfamily Ligands
F Suo, X Zhou, R Setroikromo, W Quax
Pharmaceutics 2022
STAT3-mediated osteogenesis and osteoclastogenesis in osteoporosis
Hou X, Tian F
Cell communication and signaling : CCS 2022
Can molecular dynamics facilitate the design of protein-protein-interaction inhibitors?
Honma M, Suzuki H
Nature reviews. Rheumatology 2022
The W9 peptide inhibits osteoclastogenesis and osteoclast activity by downregulating osteoclast autophagy and promoting osteoclast apoptosis
Y Kou, C Li, P Yang, D Li, X Lu, H Liu, M Li
Journal Of Molecular Histology 2021
The Effects of Receptor Activator of NF-κB Ligand-Binding Peptides on Bone Resorption and Bone Formation
F Rashed, S Kamijyo, Y Shimizu, Y Hirohashi, M Khan, Y Sugamori, R Murali, K Aoki
Frontiers in Cell and Developmental Biology 2021
Discovery of the RANKL/RANK/OPG system
H Yasuda
Journal of Bone and Mineral Metabolism 2021
Osteoclast differentiation by RANKL and OPG signaling pathways
N Udagawa, M Koide, M Nakamura, Y Nakamichi, T Yamashita, S Uehara, Y Kobayashi, Y Furuya, H Yasuda, C Fukuda, E Tsuda
Journal of Bone and Mineral Metabolism 2020
Effects of CD4+ T lymphocytes from ovariectomized mice on bone marrow mesenchymal stem cell proliferation and osteogenic differentiation
Shao BY, Wang L, Yu Y, Chen L, Gan N, Huang WM
Experimental and therapeutic medicine 2020
The protective effect of WKYMVm peptide on inflammatory osteolysis through regulating NF‐κB and CD9/gp130/STAT3 signalling pathway
J Hu, X Li, Y Chen, X Han, L Li, Z Yang, L Duan, H Lu, Q He
Journal of Cellular and Molecular Medicine 2019
The Nuclear Protein HOXB13 Enhances Methylmercury Toxicity by Inducing Oncostatin M and Promoting Its Binding to TNFR3 in Cultured Cells
T Toyama, S Xu, R Nakano, T Hasegawa, N Endo, T Takahashi, JY Lee, A Naganuma, GW Hwang
Cells 2019
Recent advances in osteoclast biology
T Ono, T Nakashima
Histochemistry and Cell Biology 2018
Gadolinium Tagged Osteoprotegerin-Mimicking Peptide: A Novel Magnetic Resonance Imaging Biospecific Contrast Agent for the Inhibition of Osteoclastogenesis and Osteoclast Activity
L Mbundi, S Meikle, R Busquets, N Dowell, M Cercignani, M Santin
Nanomaterials 2018
Occlusal disharmony-induced stress causes osteopenia of the lumbar vertebrae and long bones in mice
Y Shimizu, M Khan, G Kato, K Aoki, T Ono
Scientific Reports 2018
Effects of TNF receptor blockade on in vitro cell survival and response to negative energy balance in dairy cattle
CA Martel, LK Mamedova, JE Minton, M Garcia, C Legallet, BJ Bradford
Journal of Animal Science and Biotechnology 2018
Dysregulation of 5-hydroxytryptamine 6 receptor accelerates maturation of bone-resorbing osteoclasts and induces bone loss
KR Park, EC Kim, JT Hong, HM Yun
Theranostics 2018
LRRC15 promotes osteogenic differentiation of mesenchymal stem cells by modulating p65 cytoplasmic/nuclear translocation
Y Wang, Y Liu, M Zhang, L Lv, X Zhang, P Zhang, Y Zhou
Stem Cell Research & Therapy 2018
Inhibition of RANKL-stimulated osteoclast differentiation by Schisandra chinensis through down-regulation of NFATc1 and c-fos expression
EJ Kim, H Lee, MH Kim, WM Yang
BMC complementary and alternative medicine 2018
(−)-Epicatechin 3-O-β-d-allopyranoside prevent ovariectomy-induced bone loss in mice by suppressing RANKL-induced NF-κB and NFATc-1 signaling pathways
HB Hsiao, JB Wu, WC Lin
BMC complementary and alternative medicine 2017
Local administration of WP9QY (W9) peptide promotes bone formation in a rat femur delayed-union model
M Sawa, S Wakitani, N Kamei, S Kotaka, N Adachi, M Ochi
Journal of Bone and Mineral Metabolism 2017
Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis
Y Ozaki, M Koide, Y Furuya, T Ninomiya, H Yasuda, M Nakamura, Y Kobayashi, N Takahashi, N Yoshinari, N Udagawa, D Heymann
PloS one 2017
Three-dimensional structural analysis of the morphological condition of the alveolar bone before and after orthodontic treatment
Y Shimizu, T Ono
The Korean Journal of Orthodontics 2017
Central Leptin and Tumor Necrosis Factor-α (TNFα) in Diurnal Control of Blood Pressure and Hypertension
C Han, W Wu, A Ale, MS Kim, D Cai
The Journal of biological chemistry 2016
Peptide drugs accelerate BMP-2-induced calvarial bone regeneration and stimulate osteoblast differentiation through mTORC1 signaling
Y Sugamori, S Mise-Omata, C Maeda, S Aoki, Y Tabata, R Murali, H Yasuda, N Udagawa, H Suzuki, M Honma, K Aoki
BioEssays 2016
The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study
G Kato, Y Shimizu, Y Arai, N Suzuki, Y Sugamori, M Maeda, M Takahashi, Y Tamura, N Wakabayashi, R Murali, T Ono, K Ohya, S Mise-Omata, K Aoki
Arthritis Research & Therapy 2015
RANKL/OPG; Critical role in bone physiology
TJ Martin, NA Sims
Reviews in Endocrine and Metabolic Disorders 2015
Nanogel-crosslinked nanoparticles increase the inhibitory effects of W9 synthetic peptide on bone loss in a murine bone resorption model
K Aoki, T Sato, N Alles, M Khan, K Nagano, M Takahashi, Y Tamura, A Shimoda, K Akiyoshi, K Ohya
International Journal of Nanomedicine 2015
Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit
NA Sims, TJ Martin
BoneKEy Reports 2014
Andrographolide suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo: Andrographolide inhibits osteoclast function
ZJ Zhai, HW Li, GW Liu, XH Qu, B Tian, W Yan, Z Lin, TT Tang, A Qin, KR Dai
British Journal of Pharmacology 2014
Immunological reaction in TNF-α-mediated osteoclast formation and bone resorption in vitro and in vivo
H Kitaura, K Kimura, M Ishida, H Kohara, M Yoshimatsu, T Takano-Yamamoto
Clinical & developmental immunology 2013
Stimulation of bone formation in cortical bone of mice treated with a receptor activator of nuclear factor-κB ligand (RANKL)-binding peptide that possesses osteoclastogenesis inhibitory activity
Y Furuya, A Inagaki, M Khan, K Mori, JM Penninger, M Nakamura, N Udagawa, K Aoki, K Ohya, K Uchida, H Yasuda
The Journal of biological chemistry 2013
Control of bone resorption in mice by Schnurri-3
MN Wein, DC Jones, JH Shim, AO Aliprantis, R Sulyanto, V Lazarevic, SL Poliachik, TS Gross, LH Glimcher
Proceedings of the National Academy of Sciences 2012
Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidences
D Heymann
Journal of Bone Oncology 2012
The methionine-aromatic motif plays a unique role in stabilizing protein structure
CC Valley, A Cembran, JD Perlmutter, AK Lewis, NP Labello, J Gao, JN Sachs
The Journal of biological chemistry 2012
DMSO regulates osteoclast development in vitro
JM Lemieux, G Wu, JA Morgan, MA Kacena
In vitro cellular & developmental biology. Animal 2011
Why TNF-α inhibition is not sufficient to avoid juxta-articular erosions in chronic arthritis?
N Maruotti, F dOnofrio, A Corrado, FP Cantatore
Internal and Emergency Medicine 2011
Structure-based development of a receptor activator of nuclear factor-kappaB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis
HM Ta, GT Nguyen, HM Jin, J Choi, H Park, N Kim, HY Hwang, KK Kim
Proceedings of the National Academy of Sciences 2010
Selective inhibition of the RANK receptor by a novel cell-permeable peptide that blocks osteoclast maturation and function and prevents bone loss in vivo
Hyunsoo Kim, Han Kyoung Choi, Ji Hye Shin, Kyung Hee Kim, Ji Young Huh, Seung Ah Lee, Chang-Yong Ko, Han-Sung Kim, Hong-In Shin, Hwa Jeong Lee, Daewon Jeong, Nacksung Kim, Yongwon Choi, and Soo Young Lee
Journal of Clinical Investigation 2009
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Loss of Cbl-b increases osteoclast bone-resorbing activity and induces osteopenia
A Nakajima, A Sanjay, R Chiusaroli, NS Adapala, L Neff, C Itzsteink, WC Horne, R Baron
Journal of Bone and Mineral Research 2009
Mutations within the TNF-Like Core Domain of RANKL Impair Osteoclast Differentiation and Activation
T Cheng, NJ Pavlos, C Wang, JW Tan, JM Lin, J Cornish, MH Zheng, J Xu
Molecular Endocrinology 2009
Bovine dentine organic matrix down-regulates osteoclast activity
W Sriarj, K Aoki, K Ohya, Y Takagi, H Shimokawa
Journal of Bone and Mineral Metabolism 2009
Inhibition of the classical NF-κB pathway prevents osteoclast bone-resorbing activity
NS Soysa, N Alles, H Shimokawa, E Jimi, K Aoki, K Ohya
Journal of Bone and Mineral Metabolism 2009
Lipopolysaccharide-induced bone resorption is increased in TNF type 2 receptor-deficient mice in vivo
AH Mian, H Saito, N Alles, H Shimokawa, K Aoki, K Ohya
Journal of Bone and Mineral Metabolism 2008
Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2 −/− mice
H Gil-Henn, O Destaing, NA Sims, K Aoki, N Alles, L Neff, A Sanjay, A Bruzzaniti, PD Camilli, R Baron, J Schlessinger
The Journal of Cell Biology 2007
Osteoclasts: What Do They Do and How Do They Do It?
SL Teitelbaum
The American Journal of Pathology 2007
NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor
T Kubota, M Hoshino, K Aoki, K Ohya, Y Komano, T Nanki, N Miyasaka, K Umezawa
Arthritis Research & Therapy 2007

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 10 patents
58 readers on Mendeley
See more details